Martin-Varillas, J. L.Calvo-Rio, V.Beltran, E.Sanchez, J.Mesquida, M.Adan, A.Hernandez, M. V.Hernandez, M.Valls, E.Martinez, L.Sellas, A.Cordero, M.Diaz, M.Gallego, R.Salom, D.Ortego, N.Garcia, J. L.Callejas, J. L.Herreras, J. M.Garcia, A. M.Maiz, O.Blanco, A.Torre, I.Diaz, D.Pato, E.Aurrecoechea, E.Caracuel, M. A.Gamero, F.Minguez, E.Carrasco, C.Olive, A.Vazquez, J.Ruiz, O.Manero, J.Munoz, S.Gandia, M.Rubio, E.Toyos, F. J.Lopez, F. J.Nolla, J. M.Revenga, M.Gonzalez-Vela, C.Loricera, J.Atienza-Mateo, B.Demetrio-Pablo, R.Hernandez, J. L.Gonzalez-Gay, Ma.Blanco, R.2025-01-072025-01-072018-06-010003-4967https://hdl.handle.net/10668/25292enTherapyMAINTENANCE TREATMENT WITH ADALIMUMAB IN REFRACTORY UVEITIS DUE TO BEHCET'S DISEASE: OPTIMISED VS NON-OPTIMISED GROUPconference outputopen access10.1136/annrheumdis-2018-eular.39631468-2060https://ard.bmj.com/content/annrheumdis/77/Suppl_2/1478.2.full.pdf444351004253